
Over the past few years, several oral agents for the treatment of type 2 diabetes have become available in the United zzso zzso a zzso that has been used for decades in other countries throughout the world, improves zzso control without zzso zzso or promoting weight zzso This agent has recently been reintroduced in the United zzso zzso is an zzso inhibitor that improves zzso control by decreasing the zzso zzso of zzso thereby decreasing zzso zzso zzso The use of zzso and zzso may be limited by their side effects and potential risks, especially the risk of zzso zzso with zzso The third newly available agent, zzso has been shown to improve insulin zzso zzso of zzso zzso and zzso may facilitate improved zzso control without the use of insulin, or they may allow zzso or insulin zzso to be reduced, in this way minimizing the adverse effects of zzso Unfortunately, current oral therapies do not prevent the inevitable decline in zzso control that occurs during the natural history of type 2 zzso 

